According to DataM Intelligence, the cardiovascular, renal & metabolic diseases market size reached US$ 298.73 billion in 2024, up from US$ 286.12 billion in 2023, and is projected to grow to US$ 451.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback